Aim: Giardiasis caused by Giardia intestinalis is one of the most common intestinal parasitic diseases in humans. The measures taken during the COVID-19 pandemic period indirectly affected other infectious diseases. This study aimed to determine the frequency of G. intestinalis in a university hospital and examine the effect of the COVID-19 pandemic period on the frequency of giardiasis. Method: In this study, cases with G. intestinalis detected from stool samples in the microbiology-parasitology laboratory between January 2018 and December 2021 were included in the study. The distribution of G. intestinalis positive cases according to symptoms, age, gender, and age groups was determined. The number of patients who applied during the COVID-19 pandemic and the number of cases with G. intestinalis were evaluated. Results: In the study, G. intestinalis was detected at a rate of 0.33% (n=55) from the stool samples of 16.587 patients. The rate of giardiasis was 0.42% before the pandemic and 0.18% during the pandemic period. Of the positive patients, 61.8% (n=34) were male and 38.2% (n=21) were female, with a mean age of 19.2±18.5 (min-max:1-65). 69.1% (n=38) of giardiasis cases were pediatric patients and 30.9% (n=17) were adult patients. 70.9% (n=39) of the cases were outpatients and 29.1% (n=16) were inpatients. According to age groups, the most cases were detected in children aged 6-17 years (47.3%, n=26) and it was followed by children aged 0-5 years (21.8%, n=12), adults aged 40-65 years (16.4%, n=9) and young-adults aged 18-39 years (14.5%, n=8). During the COVID-19 pandemic period, the number of parasitology patient applications decreased by 42.2% and the number of giardiasis decreased by 75%. The highest decrease in age groups was observed in children aged 6-17 years at a rate of 91.6%. Conclusion: As a result, in this study, epidemiological data about giardiasis were obtained from our region and it was seen that the COVID-19 pandemic reduced the frequency of giardiasis. It was thought that improved hand hygiene and sustainability of infection prevention measures, which became widespread during the pandemic, may contribute to reducing the frequency of giardiasis and other gastrointestinal infections.
Amaç: Giardia intestinalis’in neden olduğu giardiyaz insanlarda en yaygın görülen intestinal parazit hastalıklarından birisidir. COVID-19 pandemi döneminde alınan önlemler diğer bulaşıcı hastalıkları da dolaylı olarak etkilemiştir. Bu çalışmada, bir üniversite hastanesinde G. intestinalis sıklığının belirlenmesi ve COVID-19 pandemi döneminin giardiyaz sıklığına etkisinin irdelenmesi amaçlanmıştır. Yöntem: Bu çalışmada, Ocak 2018-Aralık 2021 tarihleri arasında mikrobiyoloji-parazitoloji laboratuvarında dışkı örneklerinden G. intestinalis saptanan olgular çalışmaya dahil edildi. G. intestinalis pozitif bulunan olguların semptom, yaş, cinsiyet ve yaş gruplarına göre dağılımları belirlendi. COVID-19 pandeminde başvuru yapan hasta sayısı ve G. intestinalis saptanan olgu sayısı değerlendirildi. Bulgular: Çalışmada 16.587 hastanın dışkı örneğinde %0.33 (n=55) oranında G. intestinalis tespit edilmiştir. Giardiyaz oranı pandemi öncesi %0.42, pandemi dönemi %0.18 bulunmuştur. Pozitif hastaların %61.8 (n=34)’i erkek ve %38.2 (n=21)’si kadın olup yaş ortalaması 19.2±18.5 (min-maks:1-65)’dir. Giardiyaz olgularının %69.1(n=38)’i pediatrik, %30.9(n=17)’u erişkin hastalardır. Olguların %70.9 (n=39)’u ayaktan, %29.1 (n=16)’i yatan hastalarından oluşmaktadır. Yaş gruplarına göre en fazla olgu 6-17 yaş grubunda (%47.3, n=26) tespit edilmiş ve bunu <5 yaş grubu (%21.8, n=12), 40-65 yaş grubu (%16.4, n=9) ve 18-39 yaş grubu (%14.5, n=8) takip etmiştir. COVID-19 pandemi döneminde parazitoloji hasta başvuru sayısı %42.2, giardiyaz sayısı ise %75 oranında azalmıştır. Yaş gruplarında en yüksek azalma %91.6 oranında 6-17 yaş grubunda görülmüştür. Sonuç: Sonuç olarak bu çalışmada bölgemizden Giardisis hakkında epidemiyolojik veri elde edilmiş ve COVID-19 pandemisinin giardiyaz sıklığını azalttığı görülmüştür. Pandemi döneminde yaygınlaşan iyileştirilmiş el hijyeni ve enfeksiyondan korunma önlemlerinin sürdürülebilir olması, giardiyaz ve diğer gastrointestinal enfeksiyon sıklığının azalmasına katkı sağlayabileceği düşünülmüştür.
Primary Language | Turkish |
---|---|
Subjects | Health Care Administration |
Journal Section | Articles |
Authors | |
Early Pub Date | December 5, 2023 |
Publication Date | December 18, 2023 |
Submission Date | March 14, 2023 |
Acceptance Date | August 7, 2023 |
Published in Issue | Year 2023 Volume: 16 Issue: 3 |
MEU Journal of Health Sciences Assoc was began to the publishing process in 2008 under the supervision of Assoc. Prof. Gönül Aslan, Editor-in-Chief, and affiliated to Mersin University Institute of Health Sciences. In March 2015, Prof. Dr. Caferi Tayyar Şaşmaz undertook the Editor-in Chief position and since then he has been in charge.
Publishing in three issues per year (April - August - December), it is a multisectoral refereed scientific journal. In addition to research articles, scientific articles such as reviews, case reports and letters to the editor are published in the journal. Our journal, which has been published via e-mail since its inception, has been published both online and in print. Following the Participation Agreement signed with TÜBİTAK-ULAKBİM Dergi Park in April 2015, it has started to accept and evaluate online publications.
Mersin University Journal of Health Sciences have been indexed by Turkey Citation Index since November 16, 2011.
Mersin University Journal of Health Sciences have been indexed by ULAKBIM Medical Database from the first issue of 2016.
Mersin University Journal of Health Sciences have been indexed by DOAJ since October 02, 2019.
Article Publishing Charge Policy: Our journal has adopted an open access policy and there is no fee for article application, evaluation, and publication in our journal. All the articles published in our journal can be accessed from the Archive free of charge.
This work is licensed with Attribution-NonCommercial 4.0 International.